217 related articles for article (PubMed ID: 28239141)
21. The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy.
Major P
Oncologist; 2002; 7(6):481-91. PubMed ID: 12490736
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin as an active treatment in zoledronate-refractory hypercalcemia.
Lin PH; Chiu CF; Lu YS
Ann Oncol; 2011 May; 22(5):1244-1246. PubMed ID: 21460375
[No Abstract] [Full Text] [Related]
23. PTHrP-mediated hypercalcaemia in a case of CML blast crisis.
Kubonishi I; Asahi Y; Machida H; Uemura Y; Hatakeyama N; Kubota T; Ohtsuki Y; Miyoshi I
Br J Haematol; 1997 Jan; 96(1):165-7. PubMed ID: 9012703
[TBL] [Abstract][Full Text] [Related]
24. Severe hypercalcemia as a form of acute lymphoblastic leukemia presentation in children.
Martins AL; Moniz M; Nunes PS; Abadesso C; Loureiro HC; Duarte X; Almeida HI
Rev Bras Ter Intensiva; 2015; 27(4):402-5. PubMed ID: 26761480
[TBL] [Abstract][Full Text] [Related]
25. Hypercalcemia of malignancy remains a clinically relevant problem.
Van Poznak C
Cancer J; 2006; 12(1):21-3. PubMed ID: 16613658
[No Abstract] [Full Text] [Related]
26. Conventional treatment of hypercalcemia of malignancy.
Davidson TG
Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S8-15. PubMed ID: 11757206
[TBL] [Abstract][Full Text] [Related]
27. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
Cohen MH; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Jan; 11(1):12-9. PubMed ID: 15671523
[TBL] [Abstract][Full Text] [Related]
28. [Clinical study of zoledronic acid in the treatment of cancer-induced hypercalcemia].
Shen G; Song ST; Jiang ZF; Bian SG; Xie GR; Wang YJ; Wang JJ
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):632-4. PubMed ID: 16438878
[TBL] [Abstract][Full Text] [Related]
29. [Hypercalcemia revealing sarcoidosis in a child].
Kinné M; Filleron A; Salet R; Saumet L; Baron Joly S; Tran TA
Arch Pediatr; 2016 May; 23(5):508-13. PubMed ID: 27021884
[TBL] [Abstract][Full Text] [Related]
30. Hypercalcemia associated with osteolytic lesions in the extramedullary blastic crisis of chronic myelogenous leukemia: report of a case.
Kubota K; Yanagisawa T; Kurabayashi H; Ono K; Shirakura T; Nagashima K; Yatabe H; Nakazato Y
Blut; 1989 Nov; 59(5):458-9. PubMed ID: 2819252
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid sparing effect of zoledronic acid in sarcoid hypercalcemia.
Kuchay MS; Mishra SK; Bansal B; Farooqui KJ; Sekhar L; Mithal A
Arch Osteoporos; 2017 Dec; 12(1):68. PubMed ID: 28726113
[TBL] [Abstract][Full Text] [Related]
32. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
[TBL] [Abstract][Full Text] [Related]
33. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
[TBL] [Abstract][Full Text] [Related]
34. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
35. Technetium-99m MDP bone scintigraphic findings of hypercalcemia in accelerated phase of chronic myelogenous leukemia.
Kwak HS; Sohn MH; Lim ST; Kwak JY; Yim CY
J Korean Med Sci; 2000 Oct; 15(5):598-600. PubMed ID: 11069001
[TBL] [Abstract][Full Text] [Related]
36. Promyelocytic blast crisis of chronic myelogenous leukemia. A rare subtype associated with disseminated intravascular coagulation.
Rosenthal NS; Knapp D; Farhi DC
Am J Clin Pathol; 1995 Feb; 103(2):185-8. PubMed ID: 7856560
[TBL] [Abstract][Full Text] [Related]
37. Successful Management of Severe Hypercalcemia with Zoledronic Acid: A Report of Two Pediatric Cases.
Kilci F; Jones JH; Çizmecioğlu-Jones FM
J Clin Res Pediatr Endocrinol; 2024 May; 16(2):224-228. PubMed ID: 36264042
[TBL] [Abstract][Full Text] [Related]
38. Small cell carcinoma of the urinary bladder with hypercalcemia.
Sendur MA; Aksoy S; Arık Z; Yaman S; Ozdemir NY; Uncu D; Zengin N
Med Oncol; 2012 Jun; 29(2):827-8. PubMed ID: 21499925
[No Abstract] [Full Text] [Related]
39. Childhood aleukemic leukemia with hypercalcemia and bone lesions mimicking metabolic bone disease.
Ganesan P; Thulkar S; Gupta R; Bakhshi S
J Pediatr Endocrinol Metab; 2009 May; 22(5):463-7. PubMed ID: 19618667
[TBL] [Abstract][Full Text] [Related]
40. Primary hyperparathyroidism and neuropsychiatric alterations in a nonagenarian woman.
Prete C; Foppiani L; Trasciatti S; Senesi B; Veneziano M; Barone A; Palummeri E
Aging Clin Exp Res; 2005 Feb; 17(1):67-70. PubMed ID: 15847125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
